Market Tracker

01/20 5:16pm ET

Impax Laboratories Inc (NASDAQ:IPXL)

12.05
Delayed Data
As of Jan 20
 0.00 / 0.00%
Today’s Change
11.88
Today|||52-Week Range
40.74
-9.06%
Year-to-Date

Today’s Trading

Previous close12.05
Today’s open12.10
Day’s range11.95 - 12.25
Volume1,026,625
Average volume (3 months)1,284,380
Market cap$890.2M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-33.33%
Earnings growth (this year)-20.01%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+44.36%
P/E ratioNM
Price/Sales3.58
Price/Book0.82

Competitors

 Today’s
change
Today’s
% change
CLCDCoLucid Pharmaceutic...-0.05-0.11%
AIMTAimmune Therapeutics...-0.18-0.95%
INSMInsmed Inc+0.24+1.55%
CORTCorcept Therapeutics...-0.20-2.63%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateFebruary 28, 2017
EPS forecast (this quarter)$0.15
Annual revenue (last year)$860.5M
Annual profit (last year)$39.0M
Net profit margin4.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
J. Kevin Buchi
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts